Genertec Universal Medical Group saw the highest growth of 99% in patent filings in November and 549% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw no growth in patent filings and grants by 549%. GlobalData’s DataBook provides a comprehensive analysis of Genertec Universal Medical Group’s patent filings and grants. Buy the databook here.
Genertec Universal Medical Group has been focused on protecting inventions in China(CN) with 14 publications in Q4 2023
The China(CN) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The China(CN) patent Office are among the top ten patent offices where Genertec Universal Medical Group is filings its patents. Among the top granted patent authorities, Genertec Universal Medical Group has 100% of its grants in China(CN)
Patents related to climate change and nanomedicine lead Genertec Universal Medical Group's portfolio
Genertec Universal Medical Group has the highest number of patents in climate change followed by, nanomedicine and nano tech. For climate change, nearly 33% of patents were filed and 25% of patents were granted in Q4 2023.
Solar pv related patents lead Genertec Universal Medical Group portfolio followed by utilities networks
Genertec Universal Medical Group has highest number of patents in solar pv followed by utilities networks.
For comprehensive analysis of Genertec Universal Medical Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.